1. Home
  2. WWR vs CALC Comparison

WWR vs CALC Comparison

Compare WWR & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WWR
  • CALC
  • Stock Information
  • Founded
  • WWR 1977
  • CALC 2011
  • Country
  • WWR United States
  • CALC United States
  • Employees
  • WWR N/A
  • CALC N/A
  • Industry
  • WWR Metal Mining
  • CALC Biotechnology: Pharmaceutical Preparations
  • Sector
  • WWR Basic Materials
  • CALC Health Care
  • Exchange
  • WWR Nasdaq
  • CALC Nasdaq
  • Market Cap
  • WWR 36.9M
  • CALC 36.0M
  • IPO Year
  • WWR N/A
  • CALC N/A
  • Fundamental
  • Price
  • WWR $0.94
  • CALC $2.67
  • Analyst Decision
  • WWR
  • CALC Strong Buy
  • Analyst Count
  • WWR 0
  • CALC 5
  • Target Price
  • WWR N/A
  • CALC $18.20
  • AVG Volume (30 Days)
  • WWR 930.7K
  • CALC 31.3K
  • Earning Date
  • WWR 03-18-2025
  • CALC 03-27-2025
  • Dividend Yield
  • WWR N/A
  • CALC N/A
  • EPS Growth
  • WWR N/A
  • CALC N/A
  • EPS
  • WWR N/A
  • CALC N/A
  • Revenue
  • WWR N/A
  • CALC N/A
  • Revenue This Year
  • WWR N/A
  • CALC N/A
  • Revenue Next Year
  • WWR N/A
  • CALC N/A
  • P/E Ratio
  • WWR N/A
  • CALC N/A
  • Revenue Growth
  • WWR N/A
  • CALC N/A
  • 52 Week Low
  • WWR $0.40
  • CALC $2.05
  • 52 Week High
  • WWR $1.32
  • CALC $6.27
  • Technical
  • Relative Strength Index (RSI)
  • WWR 55.40
  • CALC 38.91
  • Support Level
  • WWR $0.87
  • CALC $2.59
  • Resistance Level
  • WWR $1.12
  • CALC $2.75
  • Average True Range (ATR)
  • WWR 0.13
  • CALC 0.21
  • MACD
  • WWR -0.01
  • CALC 0.01
  • Stochastic Oscillator
  • WWR 25.00
  • CALC 33.06

About WWR Westwater Resources Inc.

Westwater Resources Inc focused on developing battery-grade natural graphite materials. The company is having one project which is the Westwater's coosa project which is currently used for the mining and extraction of graphite.

About CALC CalciMedica Inc.

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening inflammatory diseases with high unmet need. Its proprietary technology targets the inhibition of calcium release-activated calcium channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases for which there are no approved therapies.

Share on Social Networks: